Literature DB >> 20823995

Successful Use of Factor VIII Concentrate and Fresh Frozen Plasma for Four Dental Extractions in an Individual with Combined Factor V and VIII Deficiency.

Hassan Mansouritorghabeh1, Zahra Rezaieyazdi, Mahshid Bagheri.   

Abstract

BACKGROUND: Combined factor V and VIII deficiency (CF5F8D) is a rare autosomal recessive disorder, with an estimated prevalence of about 1:100,000 in the Jewish population. Affected individuals have between 5 and 30% of normal levels of factor V and VIII, whereas the levels of other plasma proteins are not altered. This bleeding disorder has been treated by replacement therapy with plasma infusion and FVIII concentrate as source of factor V and VIII, respectively, depending on the severity of the haemorrhage. CASE REPORT: The individual with CF5F8D was a 22-year-old man with APTT of 51 s (control 33 s), PT of 27 s (control 12 s), factor V of 13%, and factor VIII of 21%. He had four untreatable carious teeth, including the maxillary first premolars and the mandibular first and second right molar. Factor VIII concentrate infusion began 12 h before the first dental extraction procedure and was continued in 8 h intervals. Moreover, 10 ml/kg of fresh frozen plasma were given for compensating factor V deficiency. No remarkable haemorrhage occurred during and after the procedures. The levels of factor V and VIII post procedures were 64 and 75%, respectively.
CONCLUSION: It seems that plasma levels of 6075% for both factor V and VIII may be sufficient for major dental procedures.

Entities:  

Year:  2009        PMID: 20823995      PMCID: PMC2928828          DOI: 10.1159/000205405

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  8 in total

1.  Successful use of fresh frozen plasma and desmopressin for transurethral prostatectomy in a French Basque with combined factors V +VIII deficiency.

Authors:  F Bauduer; J P Guichandut; L Ducout
Journal:  J Thromb Haemost       Date:  2004-04       Impact factor: 5.824

2.  Combined factor V and VIII deficiency: a new family and their haemorrhagic manifestations.

Authors:  H Mansouritorghabeh; Z Rezaieyazdi; A A Pourfathollah
Journal:  Haemophilia       Date:  2006-03       Impact factor: 4.287

3.  Use of plasma exchange in hereditary deficiency of factor V and factor VIII.

Authors:  A S Sallah; P Angchaisuksiri; H R Roberts
Journal:  Am J Hematol       Date:  1996-07       Impact factor: 10.047

4.  Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII.

Authors:  F Peyvandi; E G Tuddenham; A M Akhtari; M Lak; P M Mannucci
Journal:  Br J Haematol       Date:  1998-03       Impact factor: 6.998

5.  Dental extraction in a patient with congenital deficiencies of factors V and VIII.

Authors:  M Takeuchi; M Shikimori; T Kaneda
Journal:  J Oral Maxillofac Surg       Date:  1984-05       Impact factor: 1.895

6.  Combined factor V - factor VIII deficiency (F5F8D): compound heterozygosity for two novel truncating mutations in LMAN1 in a consanguineous patient.

Authors:  Roula A Farah; Philippe de Moerloose; Isabelle Bouchardy; Michael A Morris; Wadad Barakat; Alain E Sayad; Marguerite Neerman-Arbez
Journal:  Thromb Haemost       Date:  2006-05       Impact factor: 5.249

7.  Haemorrhagic symptoms in patients with combined factors V and VIII deficiency in north-eastern Iran.

Authors:  H Mansouritorgabeh; Z Rezaieyazdi; A A Pourfathollah; J Rezai; H Esamaili
Journal:  Haemophilia       Date:  2004-05       Impact factor: 4.287

8.  [Congenital factor V deficiency (parahemophilia) with true hemophilia in two brothers].

Authors:  J OERI; M MATTER; H ISENSCHMID; F HAUSER; F KOLLER
Journal:  Bibl Paediatr       Date:  1954
  8 in total
  6 in total

1.  Clinically Oriented Research in Transfusion Medicine.

Authors:  Petra Krakowitzky; Walter Sibrowski
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 2.  Combined deficiency of coagulation factors V and VIII: an update.

Authors:  Chunlei Zheng; Bin Zhang
Journal:  Semin Thromb Hemost       Date:  2013-07-12       Impact factor: 4.180

3.  Clinical Care of Bone Health in Patients on the Immune Tolerance Induction's Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia.

Authors:  Zahra Rezaieyazdi; Hassan Mansouritorghabeh
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

4.  Mining of mortality-related findings in rare bleeding disorders: a retrospective study from two centers.

Authors:  Hassan Rafieemehr; Akbar Dorgalaleh; Hassan Mansouritorghabeh
Journal:  Blood Res       Date:  2020-11-24

5.  Parvovirus 4 in Individuals with Severe Hemophilia A and Matched Control Group.

Authors:  Sanaz Asiyabi; Seyed Mahdi Marashi; Rouhollah Vahabpour; Ahmad Nejati; Alireza Azizi-Saraji; Aliyeh Sadat Mustafa; Asgar Baghernejad; Zabiholla Shoja; Hassan Mansouritorghabeh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2021-07-01

6.  Successful Pregnancy in a Patient with Combined Deficiency of Factor V and Factor VIII.

Authors:  Ahmed Ghassan El Adib; Farah Majdi; Mohamed Othmane Dilai; Hamid Asmouki; Ahlam Bassir; Karam Harou; Abderraouf Soumani; Said Younous; Lahoucine Mahmal
Journal:  Case Rep Obstet Gynecol       Date:  2014-05-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.